BAG3 regulates epithelial-mesenchymal transition and angiogenesis in human hepatocellular carcinoma

Laboratory Investigation

Volumn 94, Issue 3, 2014, Pages 252-261

  Xiao, Heng ^a,b   Cheng, Shaobing ^a,b   Tong, Rongliang ^a,b   Lv, Zheng ^a   Ding, Chaofeng ^a   Du, Chengli ^a   Xie, Haiyang ^b   Zhou, Lin ^b   Wu, Jian ^b   Zheng, Shusen ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

angiogenesis; Bcl2 associated athanogene 3; epithelial mesenchymal transition; human hepatocellular carcinoma

Indexed keywords

AUTOPHAGY PROTEIN 5; BCL2 ASSOCIATED ATHANOGENE 3 PROTEIN; CD34 ANTIGEN; GELATINASE A; HEAT SHOCK PROTEIN; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CANCER GROWTH; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; ANIMALS; ANTIGENS, CD34; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896817592     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.151     Document Type: Article

References (35)

1. Takayama S, Reed JC. Molecular chaperone targeting and regulation by BAG family proteins. Nat Cell Biol 2001;3:237-241.
2. Takayama S, Xie Z, Reed. JC. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 1999;274: 781-786.
3. Rosati A, Ammirante M, Gentilella A, et al. Apoptosis inhibition in cancer cells: A novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol 2007;39:1337-1342.
4. Romano MF, Festa M, Petrella A, et al. BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol Ther 2003;2:508-510.
5. Chiappetta G, Ammirante M, Basile A, et al. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Clin Endocrinol Metab 2007;92:1159-1163.
6. Gentilella A, Passiatore G, Deshmane S, et al. Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells. Oncogene 2008; 27:5011-5018.
7. Staibano S, Mascolo M, Benedetto M, et al. BAG3 protein delocalisation in prostate carcinoma. Tumor Biol. 2010;31:461-469.
8. Wang H-Q, Meng X, Gao Y-Y, et al. Characterization of BAG3 cleavage during apoptosis of pancreatic cancer cells. J Cell Physiol 2010;224: 94-100.
9. Suzuki M, Iwasaki M, Sugio A, et al. BAG3 (BCL2-Associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett 2011;303; 65-71.
10. Festa M, Del Valle L, Khalili K, et al. BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol 2011;178:2504-2512.
11. Rosati A, Graziano V, De Laurenzi V, et al. BAG3: A multifaceted protein that regulates major cell pathways. Cell Death Dis 2011;7:141.
12. Falco A, Festa M, Basile A, et al. BAG3 controls angiogenesis through regulation of ERK phosphorylation. Oncogene 2012;31:5153-5161.
13. Li N, Du ZX, Zong ZH, et al. PKC[delta]-mediated phosphorylation of BAG3 at Ser187 site induces epithelial-mesenchymal transition and enhances invasiveness in thyroid cancer FRO cells. Oncogene 2012;32: 4539-4548.
14. He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124-1134.
15. Pang RC, Joh J, Johnson P, et al. Biology of hepatocellular carcinoma. Ann Surg Oncol 2008;15:962-971.
16. Semenza GL. HIF-1 and tumor progression: Pathophysiology and therapeutics. Trends Mol Med 2002;8:S62-S67.
17. Déry M-A.C., Michaud MD, Richard DE. Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005;37:535-540.
18. De A, De A, Papasian C, et al. Extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors. PLoS ONE 2013;8:e72748.
19. Kim KW, Paul P, Qiao J, et al. Enhanced autophagy blocks angiogenesis via degradation of gastrin-releasing peptide in neuroblastoma cells. Autophagy 20139.
20. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-573.
21. Sengupta N, MacDonald TT. The role of matrix metalloproteinases in stromal/epithelial interactions in the gut. Physiology 2007;22: 401-409.
22. Polette M, Nawrocki-Raby B, Gilles C, et al. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol 2004;49:179-186.
23. Iwasaki M, Homma S, Hishiya A, et al. BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer Res 2007;67:10252-10259.
24. Naber HPH, Wiercinska E, ten Dijke P, et al. Spheroid assay to measure TGF-b-induced invasion. J Vis Exp 2011;16:3337.
25. Zhang K, Chen D, Jiao X, et al. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Lab Invest 2011;91: 426-438.
26. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial- mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005;17:548-558.
27. Mimeault M, Batra SK. Interplay of distinct growth factors during epithelial-mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann Oncol 2007;18: 1605-1619.
28. Andersen H, Mejlvang J, Mahmood S, et al. Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol Cell Biol 2005;25: 9138-9150.
29. Thiery JP, Acloque H, Huang RYJ, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-890.
30. Arias AM. Epithelial mesenchymal interactions in cancer and development. Cell 2001;105:425-431.
31. Boló s V, Peinado H, Pérez-Moreno MA, et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell Sci 2003;116:499-511.
32. Naber HPH, Drabsch Y, Snaar-Jagalska BE, et al. Snail and Slug, key regulators of TGF-b-induced EMT, are sufficient for the induction of single-cell invasion. Biochem Biophys Res Commun 2013;435:58-63.
33. Toiyama Y, Yasuda H, Saigusa S, et al. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer. Carcinogenesis 2013;34: 2548-2557.
34. Ammirante M, Rosati A, Arra C, et al. IKKg protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci 2010; 107:7497-7502.
35. Fu J, Chen Y, Cao J, et al. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1a pathways. Hepatology 2011;53:181-192.